X-Bolt Orthopaedics achieved FDA 510(k) clearance to market the X-Bolt Hip Nailing and Hip Plating fixation systems.
These systems received CE Mark approval in 2011 and have been the subject of two large clinical trials, WHITE1 (100 subjects) and WHITE4 (1,140 subjects), the latter of which is the largest ever trial comparing extracapsular hip fracture fixation devices; it completed recruitment at the beginning of 2Q18. The trial is being independently run by Oxford University’s Clinical Trials and Research Unit.
Source: X-Bolt Orthopaedics
X-Bolt Orthopaedics achieved FDA 510(k) clearance to market the X-Bolt Hip Nailing and Hip Plating fixation systems.
These systems received CE Mark approval in 2011 and have been the subject of two large clinical trials, WHITE1 (100 subjects) and WHITE4 (1,140 subjects), the...
X-Bolt Orthopaedics achieved FDA 510(k) clearance to market the X-Bolt Hip Nailing and Hip Plating fixation systems.
These systems received CE Mark approval in 2011 and have been the subject of two large clinical trials, WHITE1 (100 subjects) and WHITE4 (1,140 subjects), the latter of which is the largest ever trial comparing extracapsular hip fracture fixation devices; it completed recruitment at the beginning of 2Q18. The trial is being independently run by Oxford University’s Clinical Trials and Research Unit.
Source: X-Bolt Orthopaedics
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
